ML firm Insitro Secures $143 Million in Funding to Focus on Automation

Machine learning, ML, automation, funding, Insitro, R&D, predictive models ,human disease
ML firm Insitro Secures _143 Million in Funding to Focus on Automation

Machine learning startup Insitro has announced it has raised $143 million in Series B funding. The latest funding was led by Andreessen Horowitz, with participation from new and existing investors.

COVID-19 Financial Crisis – Best Time to Start with a Blank Slate

Insitro plans to use the latest funding to focus on automation and expanding the capabilities to generate predictive models of human disease. In addition, the capital will be used to establish synergistic industry partnerships and build additional ML-enabled capabilities along the R&D value chain for drug discovery.

Source: https://www.forbes.com/sites/leahrosenbaum/2020/05/26/exclusive-machine-learning-company-insitro-raises-143-million-to-bridge-biology-and-ai/#506abafd2698

The Biggest CIOs Challenges in 2020

Previous articleOrganizations Need To Watch Out for Remote Hiring Challenges
Next articleSelf-Service Business Intelligence Is a Must-Have for Enterprises